¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"carbon dioxide compensation point"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • carbon tetrachloride
    »ç¿°È­Åº¼Ò
  • carbon tetrachloride poisoning
    »ç¿°È­Åº¼ÒÁßµ¶
  • equivalent carbon
    ´ç·®Åº¼Ò
  • acupuncture point
    °æÇ÷Á¡
  • blind point
    ¸ÍÁ¡
  • boiling point
    ²ú´ÂÁ¡, ºñµîÁ¡
  • conjugate point
    1. ÄÓ·¹Á¡ 2. °áÇÕÁ¡
  • corresponding point
    ´ëÀÀÁ¡
  • craniometric point
    ¸Ó¸®°èÃøÁ¡, µÎ°³°èÃøÁ¡
  • critical point
    ÀÓ°èÁ¡
  • cardinal point
    ±âº»Á¡
  • cut-off point
    °áÁ¤Á¡
  • dew point determination apparatus
    ³ëÁ¡°è
  • disparate point
    ºñ´ëÀÀÁ¡
  • exclamation point hair
    °¨ÅººÎÈ£ÅÐ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • equivalent carbon
    ´ç·®Åº¼Ò
  • residual carbon
    ÀÜ¿©Åº¼Ò
  • total organic carbon
    ÃÑÀ¯±âź¼Ò
  • dew point determination apparatus
    ³ëÁ¡°è
  • gingival point angle
    ÀÕ¸ö¸ð¼­¸®°¢
  • melting point determination apparatus
    À¶Á¡ÃøÁ¤±â
  • mesiobuccoocclusal point angle
    ¾ÈÂʺ¼Âʱ³ÇÕ¸éÁ¡°¢
  • mesiolinguaoocclusal point angle
    ¾ÈÂÊÇôÂʱ³ÇÕ¸éÁ¡°¢
  • boiling point
    ²ú´ÂÁ¡, ºñµîÁ¡
  • cardinal point
    ±âº»Á¡
  • conjugate point
    ÄÓ·¹Á¡, °áÇÕÁ¡
  • corresponding point
    ´ëÀÀÁ¡
  • craniometric point
    µÎ°³°èÃøÁ¡, ¸Ó¸®°èÃøÁ¡
  • critical point
    ÀÓ°èÁ¡
  • cut-off point
    °áÁ¤Á¡
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • point discharge
    Á¡¹æÀü.
  • point epidemic
    µ¹¿¬À¯Çà(ËôÌ´).
  • point estimation
    Á¡ÃßÁ¤¹ý(ËøÌ§ËøËÑ).
  • point mutation
    Á¡ µ¹¿¬º¯ÀÌ
  • point mutation
    Á¡µ¹¿¬º¯ÀÌ
  • point of basal convergence
    ±âÃÊÆøÁÖÁ¡(Ðñõ¨ÜßñÍïÇ).
  • point of condensation
    ÀÀÁýÁ¡(ëêó¢ïÇ).
  • point of convergence
    ÆøÁÖÁ¡(ÜßñÍïÇ).
  • point of fixation =p. of regard, fixa
    ÁÖ½ÃÁ¡(ñ¼ãÊïÇ).
  • point of maximal impulse
    ÃÖ´ë¹Úµ¿Á¡.
  • point of regard
    ÁÖ½ÃÁ¡.
  • point of symmetry
    ´ëĪÁ¡(ÓßöàïÇ).
  • point off axis
    ÃàÀÌÅ»ÁöÁ¡
  • point outside field
    Á¶»ç¿µ¿ª¹ÛÁöÁ¡
  • point prevalence
    ½ÃÁ¡À¯º´¼ö(ËàËøËôËÓ ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • compensation
    ´ë»ó, º¸»ó
  • compensation
    ´ë»ó, º¸»ó
  • compensation act
    º¸»ó¹ý(ËÓË×ËÑ).
  • compensation method
    º¸»ó¹ý(ÜÍßÁÛö), ´ë»ó¹ý(ÓÛßÁÛö).
  • compensation neurosis
    º¸»ó½Å°æÁõ(ÜÍßÁãêÌèñø).
  • depth compensation
    ½Éµµº¸»ó.
  • depth gain compensation
    ±íÀÌ °ÔÀÎ(°­µµ) º¸»ó
  • flow compensation
    À¯µ¿ º¸»ó
  • flow compensation gradient technique
    À¯µ¿ º¸»ó °æ»ç ±â¹ý
  • internal compensation
    ºÐÀÚ³»º¸»ó(ÝÂí­Ò® ÜÍßÁ).
  • motion compensation gradient
    ¿îµ¿ º¸»ó °æ»ç
  • neurosis, compensation
  • renal compensation
    ½Å¼º´ë»ó(ãìàõÓÛßÁ).
  • renal compensation
    ½Åº¸»ó.
  • respiratory compensation
    È£Èí¼º ´ë»ó(¡­àõÓÛßÁ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • isoelectrophoretic point
    µîÀü Àü±â¿µµ¿Á¡(Ôõï³ï³Ñ¨ç¶ÔÑïÇ)
  • isoionic point
    µî(Ôõ)À̿ Á¡(ïÇ)
  • isoprotic point
    µî¾çÀÚ Á¡(ÔõåÕí­ïÇ)
  • isosbestic point
    µîÈí±¤Á¡(ÔõýåÎÃïÇ)
  • melting point
    À¶ÇØÁ¡(ë×ú°ïÆ)
  • point mutation
    Á¡º¯ÀÌ(ïÃܨì¶)
  • point quenching
    Á¡¼ÒÆÎ(ïÃá¼ÎÃ)
  • point symmetry
    Á¡´ëĪ(ïÃÓßöà)
  • restriction point
    Á¦ÇÑÁ¡(ð¤ùÚïÃ)
  • R point
    (å²) Restriction point
  • thermal death point
    ¿­»çÁ¡(æðÞÝïÃ)
  • thermal inactivation point
    ¿­ºÒȰ¼ºÈ­Á¡ (æðÝÕüÀàõûùïÃ)
  • three-point attachment
    ¼¼°÷ ºÎÂø(Üõó·)
  • three-point cross
    ¼¼Á¡ ±³Â÷(Îßó©)
  • three-point landing
    ¼¼°÷ ¾É±â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ECCO2R extracorporeal carbon dioxide removal
ETCO2 end-tidal carbon dioxide [concentration]
ETPCO2 end-tidal partial carbon dioxide [concentration]
FECO2 fractional concentration of carbon dioxide in expired gas
FiCO2, FICO2 fractional concentration of carbon dioxide in inspired gas
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
NO2 Nitrogen Dioxide
TiO2 Titanium dioxide
CCP critical control point
CPD Critical point drying
GPA Grade Point Average
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Barker's point
    ¹Ù¾ÆÄ¿ Á¡
    ¿ÜÀ̵µÀÇ Áß¾ÓÀÇ µÚÂÊ 1.25 ÀÎÄ¡, À§ÂÊ 1.25 ÀÎÄ¡ÀÎ Á¡.
  • boiling point
    ºñÁ¡, ºñµîÁ¡, ²ú´Â Á¡
  • breaking point
    ÆÄ´ÜÁ¡
  • central bearing point
    Á᫐ ÁöÁöÁ¡
    Áß¾Ó ÁöÁö ÀåÄ¡ÀÇ Á¢ÃËÁ¡.
  • central point artifact
    Áß½ÉÁ¡ Àΰø¹°
  • conjugate point
    °ø¾× Á¡, ÄÓ·¹ Á¡, °áÇÕ Á¡
  • cutaneous trigger point
    ÇǺΠ¹ßÅëÁ¡
  • dew point
    ³ëÁ¡
  • distal point therapy
    ¿øµµ ÃëÇ÷ ¿ä¹ý
  • equivalence point
    ´ç·® Á¡
  • fixed point
    °íÁ¤Á¡
  • focal point
    ÃÊÁ¡
    ºûÀÌ Áý±¤ ·»Á ÅëÇØ Áö³ª°¥ ¶§ ±¤¼ÓÀÌ ÃÖ´ëÇÑ ³óÃàµÈ À§Ä¡.
  • freezing point depression
    ¾î´Â Á¡ °­ÇÏ
  • idiopathic trigger point mechanism
    Ư¹ß¼º ¹ßÅëÁ¡ ±âÀü
  • itchy point
    ¼Ò¾çÁ¡
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
thorium dioxide <chemical> Thorium oxide (tho2). A radiographic contrast agent that was used in the early 1930s through about 1954. High rates of mortality have been linked to its use and it has been shown to cause liver cancer.
Pharmacological action: carcinogens.
Chemical name: Thorium oxide (ThO2)
(12 Dec 1998)
titanium dioxide TiO2;contains not less than 99.0% and not more than 100.5% of TiO2, calculated on the dry basis; used in creams and powders as a protectant against external irritations and solar rays.
(05 Mar 2000)
1,4-diethylene dioxide 1,4-dioxane;a colourless liquid used as a solvent for cellulose esters and in histology as a drying agent.
Synonym: 1,4-diethylene dioxide.
(05 Mar 2000)
anomeric carbon The reducing carbon of a sugar; C-1 of an aldose, C-2 of a 2-ketose.
(05 Mar 2000)
carbon <chemistry, element> Sixth element (Z=6) in the periodic table, has 6 protons, often described as the basis of life on earth because of its chemical properties, has potential for use with silicon as a low-activation structural material for fusion reactors, in the form silicon carbide.
Carbon tiles are often used in plasma-facing components because its low Z makes carbon a relatively nice impurity. It is also useful as a neutron moderator.
See: low-activation materials, plasma-facing components.
Abbreviation: C
(13 Nov 1997)
carbon-11 A cyclotron-produced, positron-emitting radioisotope of carbon with a half-life of 20.3 minutes; used in positron-emitting tomography.
(05 Mar 2000)
carbon-12 The standard of atomic mass, 98.90% of natural carbon.
(05 Mar 2000)
carbon-13 A stable natural isotope, 1.1% of natural carbon.
(05 Mar 2000)
carbon-14 A beta-emitter with a half-life of 5715 years, widely used as a tracer in studying various aspects of metabolism; naturally occurring 14C, arising from cosmic ray bombardment, is used to date relics containing natural carbonaceous materials.
(05 Mar 2000)
carbon bisulfide <chemical> Carbon disulfide (cs2). A colourless, flammable, poisonous liquid, cs2. It is used as a solvent, and is a counterirritant and has local anaesthetic properties but is not used as such. It is highly toxic with pronounced CNS, haematologic, and dermatologic effects.
Chemical name: Carbon disulfide
(12 Dec 1998)
carbon compounds, inorganic Inorganic compounds that contain carbon as an integral part of the molecule but are not derived from hydrocarbons.
(12 Dec 1998)
carbon dichloride An anthelmintic against hookworm and other nematodes.
Synonym: carbon dichloride, ethylene tetrachloride, tetrachloroethylene.
(05 Mar 2000)
carbon disulfide <chemical> Carbon disulfide (cs2). A colourless, flammable, poisonous liquid, cs2. It is used as a solvent, and is a counterirritant and has local anaesthetic properties but is not used as such. It is highly toxic with pronounced CNS, haematologic, and dermatologic effects.
Chemical name: Carbon disulfide
(12 Dec 1998)
carbon disulfide poisoning Acute or chronic intoxication by CS2, an industrial condition encountered among rubber workers and makers of artificial silk (rayon) by the viscose process; characterised by insomnia, listlessness, and irritability, followed by paralyses, impaired vision, peptic ulcer, and psychoses.
(05 Mar 2000)
carbon fixation <plant biology> The process by which photosynthetic organisms such as plants turn inorganic carbon (usually carbon dioxide) into organic compounds (us. Carbohydrates).
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Curie point (temperature)
    Äû¸®Á¡(¿Âµµ)(Àڱ⠺¯Å°¡ ÀϾ´Â ¿Âµµ)
  • Point Four
    Á¦4Á¤Ã¥(Truman ´ëÅë·ÉÀÇ ¹Ì°³¹ß Áö¿ª °æÁ¦ ¿øÁ¶ Á¤Ã¥)
  • ball point pen
    º¼Ææ
  • black point
    Èæ¼öº´
  • boiling point
    ºñµîÁ¡
  • bradkeven point
    ä»êÁ¡
  • burning point
    ¹ßÈ­Á¡
  • cover point
    ÈÄÀ§
  • critical point
    ÀÓ°èÁ¡
  • dead point
    =DEAD CENTER
  • decimal point
    ¼Ò¼öÁ¡
  • dew point
    (±â»ó)(¿ÂµµÀÇ)À̽½Á¡;³ëÁ¡
  • dropoff point
    ¹è´Þǰ Àü´Þ Àå¼Ò;(À¯±« »ç°Ç µî¿¡¼­)¸ö°ªÀ» µÎ°í °¡´Â Àå¼Ò
  • end point
    Á¾·áÁ¡;Á¾Á¡;(È­)(ÀûÁ¤ÀÇ)Á¾Á¡;=ENDPOINT
  • equinoctial point
    (õ)ºÐÁ¡;ÁÖ¾ß ÆòºÐÁ¡
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á